Bifunctional purine synthesis protein

from Wikipedia, the free encyclopedia
Bifunctional purine synthesis protein
Bifunctional purine synthesis protein
Surface / band model of the PURH dimer according to PDB  1PKX . The AICAR formyltransferase domain is yellow and the IMP cyclohydrolase is rendered in blue.

Existing structural data : 1P4R , 1PKX , 1PL0

Properties of human protein
Mass / length primary structure 592 amino acids
Secondary to quaternary structure Homodimer
Identifier
Gene name ATIC
External IDs
Enzyme Classifications
EC, category 2.1.2.3 transferase
Response type Transfer of a formyl residue
Substrate 10-formyl-THF + AICAR
Products THF + FAICAR
EC, category 3.5.4.10 hydrolase
Response type Cyclizing dehydration
Substrate FAICAR
Products IMP + H 2 O
Occurrence
Parent taxon Creature
Orthologue
human House mouse
Entrez 471 108147
Ensemble ENSG00000138363 ENSMUSG00000026192
UniProt P31939 Q9CWJ9
Refseq (mRNA) NM_004044 NM_026195
Refseq (protein) NP_004035 NP_080471
Gene locus Chr 2: 215.31 - 215.35 Mb Chr 1: 71.56 - 71.58 Mb
PubMed search 471 108147

The bifunctional Purinsyntheseprotein (ATIC, PURH) is the enzyme that, the last two steps in the de novo biosynthesis of inosine monophosphate (IMP), the formylation and subsequent dehydration of AICAR catalyzed . The individual enzyme functions are called AICAR formyltransferase and IMP cyclohydrolase . PURH occurs in all living things and the bifunctionality is preserved everywhere. Mutations in ATIC - gene of man can PURH deficiency and this AICA Ribosurie cause a rare inherited disorder.

PURH activity is increased by phosphorylation ; PURH is phosphorylated in several tumor cell lines .

Catalyzed reactions

AICAR+ 10-formyl THFFAICAR+ THF

AICAR is formylated to FAICAR.

FAICARIMP+ H 2 O

FAICAR cyclizes with elimination of water to IMP.

The AICAR formyltransferase domain (amino acids 199-592) and the IMP cyclohydrolase domain (1-199) are 50 Å apart and retain their activity when expressed separately.

Individual evidence

  1. Orthologist at OMA
  2. UniProt P31939
  3. Boccalatte FE, Voena C, Riganti C, et al. : The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase / IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL . In: Blood . 113, No. 12, March 2009, pp. 2776-90. doi : 10.1182 / blood-2008-06-161018 . PMID 18845790 . PMC 2661863 (free full text).
  4. Cheong CG, Wolan DW, Greasley SE, Horton PA, Beardsley GP, Wilson IA: Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase / IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates . In: J. Biol. Chem. . 279, No. 17, April 2004, pp. 18034-45. doi : 10.1074 / jbc.M313691200 . PMID 14966129 .
  5. Rayl EA, Moroson BA, Beardsley GP: The human pure gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase / IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping . In: J. Biol. Chem. . 271, No. 4, January 1996, pp. 2225-33. doi : 10.1074 / jbc.271.4.2225 . PMID 8567683 .

Web links